Advances in Research and Care for Myasthenia Gravis

At the 2024 MDA Myasthenia Gravis Virtual Learning Series, Dr. Srikanth Muppidi, MD (Stanford University), presents information regarding the most recent advances in research and care for MG. This includes receiving an MG diagnosis, traditional and recently approved therapies, and therapies that are currently in development. After Dr. Muppidi’s presentation, he leads a drug development roundtable discussion regarding new developments in pharmaceutical options for Myasthenia Gravis.
Thank you to our virtual learning series sponsors, Alexion, argenx, Genentech, and GCB for their generous support.
For more information on MDA’s Virtual Learning Programs, please visit www.mda.org/care/community-ed.